Article

Comparison of normalization methods with microRNA microarray.

Bioinformatics Center, The Center of Functional Genomics, Key Lab of System Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, People's Republic of China.
Genomics (Impact Factor: 2.79). 09/2008; 92(2):122-8. DOI: 10.1016/j.ygeno.2008.04.002
Source: PubMed

ABSTRACT MicroRNAs (miRNAs) are a group of RNAs that play important roles in regulating gene expression and protein translation. In a previous study, we established an oligonucleotide microarray platform to detect miRNA expression. Because it contained only hundreds of probes, data normalization was difficult. In this study, the microarray data for eight miRNAs extracted from inflamed rat dorsal root ganglion (DRG) tissue were normalized using 15 methods and compared with the results of real-time polymerase chain reaction. It was found that the miRNA microarray data normalized by the print-tip loess method were the most consistent with results from real-time polymerase chain reaction. Moreover, the same pattern was also observed in 14 different types of rat tissue. This study compares a variety of normalization methods and will be helpful in the preprocessing of miRNA microarray data.

0 Bookmarks
 · 
154 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: MicroRNAs (miRNAs) are small (∼22-nt), stable RNAs that critically modulate post-transcriptional gene regulation. MicroRNAs can be found in the blood as components of serum, plasma and peripheral blood mononuclear cells (PBMCs). Many microRNAs have been reported to be specific biomarkers in a variety of non-neoplastic diseases. To date, no one has globally evaluated these proposed clinical biomarkers for general quality or disease specificity. We hypothesized that the cellular source of circulating microRNAs should correlate with cells involved in specific non-neoplastic disease processes. Appropriate cell expression data would inform on the quality and usefulness of each microRNA as a biomarker for specific diseases. We further hypothesized a useful clinical microRNA biomarker would have specificity to a single disease. We identified 416 microRNA biomarkers, of which 192 were unique, in 104 publications covering 57 diseases. One hundred and thirty-nine microRNAs (33%) represented biologically plausible biomarkers, corresponding to non-ubiquitous microRNAs expressed in disease-appropriate cell types. However, at a global level, many of these microRNAs were reported as "specific" biomarkers for two or more unrelated diseases with 6 microRNAs (miR-21, miR-16, miR-146a, miR-155, miR-126 and miR-223) being reported as biomarkers for 9 or more distinct diseases. Other biomarkers corresponded to common patterns of cellular injury, such as the liver-specific microRNA, miR-122, which was elevated in a disparate set of diseases that injure the liver primarily or secondarily including hepatitis B, hepatitis C, sepsis, and myocardial infarction. Only a subset of reported blood-based microRNA biomarkers have specificity for a particular disease. The remainder of the reported non-neoplastic biomarkers are either biologically implausible, non-specific, or uninterpretable due to limitations of our current understanding of microRNA expression.
    PLoS ONE 02/2014; 9(2):e89565. DOI:10.1371/journal.pone.0089565 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this paper it is introduced a new methodology for the analysis of barcode sequences. Barcode DNA is a very short nucleotide se-quence, corresponding for the animal kingdom to the mitochondrial gene cytochrome c oxidase subunit 1, that acts as a unique element for identi-fication and taxonomic purposes. Traditional barcode analysis uses well consolidated bioinformatics techniques such as sequence alignment, com-putation of evolutionary distances and phylogenetic trees. The proposed alignment-free approach consists in the use of two different compression-based approximations of Universal Similarity Metric in order to compute dissimilarity matrices among barcode sequences of 20 datasets belonging to different species. From these matrices phylogenetic trees are com-puted and compared, in terms of topology and branch length, with trees built from evolutionary distance. The results show high similarity values between compression-based and evolutionary-based trees allowing us to consider the former methodology worth to be employed for the study of barcode sequences
    Computational Intelligence Methods for Bioinformatics and Biostatistics, Edited by Leif Peterson, Francesco Masulli, Giuseppe Russo, 01/2013: chapter A Study of Compression–Based Methods for the Analysis of Barcode Sequences: pages 105-116; Springer Berlin Heidelberg.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: MicroRNAs (miRNAs) participate in important processes of life course. Due to their characters of small sizes, vulnerable degradabilities and sequences similarities, the existing detection technologies mostly contain enzymatic amplification reactions for acquisition of high sensitivities and specificities. But specific reaction conditions and time-dependent enzyme activities are caused by the accession of enzymes. Herein, we designed a target-triggered enzyme-free amplification platform that realizes by circulatory interactions of two hairpin probes and the integrated electrochemiluminescence (ECL) signal giving-out component. Benefited from outstanding performances of the enzyme-free amplification system and ECL, this strategy is provided with simplified reaction process, high sensitivity and operating under the isothermal condition. Through detections of the miRNA standard substance, the sensitivity of this platform reached at 10fmol, and a splendid specificity was achieved. We also analyzed three tumor cell lines (human lung adenocarcinoma, breast adenocarcinoma and hepatocellular liver carcinoma cell lines) through this platform. The sensitivities of 103 cells, 104 cells and 104 cells were respectively achieved. Furthermore, clinical tumor samples were tested, and 21 of 30 experimental samples gave out the positive signals. Thus, this platform possesses potentials to be an innovation in miRNA detection methodology.
    Analytical Chemistry 04/2014; 86(9). DOI:10.1021/ac5007427 · 5.83 Impact Factor

Full-text (2 Sources)

Download
75 Downloads
Available from
Jun 4, 2014